The Hidden Dangers of Thyroid Supplementation in Metabolically Compromised Horses

Levothyroxine supplementation, when used inappropriately, can significantly elevate cortisol levels through several mechanisms. When synthetic T4 (Such as Thyro-L) is introduced without proper assessment of the horse's conversion capacity and overall endocrine status, it can overstimulate the hypothalamic-pituitary-adrenal (HPA) axis. This stimulation triggers increased cortisol production from the adrenal cortex.

The relationship between elevated cortisol and insulin resistance is well-established and particularly problematic. Cortisol acts as a potent insulin antagonist by promoting gluconeogenesis in the liver, reducing glucose uptake in peripheral tissues, and interfering with insulin receptor sensitivity. In a horse already struggling with insulin resistance, this cortisol-mediated increase in blood glucose and further reduction in insulin sensitivity can push the animal toward a dangerous metabolic crisis, potentially triggering laminitis or exacerbating existing metabolic dysfunction.

Risk of Thyroid Gland Suppression and Atrophy

Research in human medicine reveals alarming consequences of inappropriate levothyroxine use that are directly applicable to horses. Long-term use of levothyroxine, particularly at higher doses, can lead to complete suppression of the hypothalamic-pituitary-thyroid axis, resulting in thyroid gland atrophy and potentially permanent dysfunction, or worse, complete failure.

When synthetic thyroid hormone is provided exogenously, the natural feedback loop is disrupted. The pituitary gland reduces or stops producing thyroid-stimulating hormone (TSH) because it detects adequate thyroid hormone levels in circulation. This TSH suppression can lead to significant atrophy of the thyroid gland itself, as the tissue essentially "shuts down" due to lack of stimulation.

Human studies demonstrate that TSH suppression therapy, even when medically indicated for thyroid cancer patients, carries substantial risks, including bone loss, cardiovascular complications, and cognitive dysfunction. In one comprehensive analysis, patients receiving TSH-suppressive doses of levothyroxine showed decreased bone mineral density and increased risk of cardiac arrhythmias. Perhaps most concerning, research indicates that once thyroid atrophy occurs from prolonged TSH suppression, some cases may result in permanent thyroid dysfunction requiring lifelong hormone replacement.

In horses with already compromised endocrine function due to insulin resistance and Lyme disease, this risk of iatrogenic thyroid failure is particularly dangerous. What begins as an attempt to treat perceived thyroid dysfunction could result in actual, permanent thyroid dysfunction that is far more severe than the original condition.

FDA Contraindications: Weight Loss and Obesity

Human medicine provides clear regulatory warnings that directly contradict common thyroid supplementation practices in horses. The FDA has issued explicit black box warnings—the strongest form of medical warning—stating that "thyroid hormones, including levothyroxine, should not be used for weight loss or to treat obesity."

This FDA warning specifically states: "Levothyroxine (a thyroid hormone) should not be used alone or along with other treatments to treat obesity or cause weight loss. Levothyroxine may cause serious or life-threatening problems when given in large doses, especially when taken with amphetamines." The warning continues: "In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may produce serious or even life-threatening manifestations of toxicity."

This regulatory stance is particularly relevant to equine practice, where levothyroxine is frequently prescribed for overweight horses under the assumption of thyroid-related weight gain. However, research shows that apparent thyroid dysfunction in overweight animals is more often secondary to metabolic dysfunction rather than primary thyroid disease. Using levothyroxine for weight management in metabolically compromised horses exposes the animal to unnecessary cardiovascular, metabolic, and endocrine risks. Particularly in an already metabolically compromised horse.

The Inadequacy of Limited Thyroid Testing

Relying solely on T4 levels, or even T4 and TSH, provides an incomplete and potentially misleading picture of thyroid function. True thyroid assessment requires a comprehensive panel including T4, T3, TSH, reverse T4 (rT4), and reverse T3 (rT3).

Here's why each component matters:

T4 (Thyroxine) represents the inactive storage form of thyroid hormone and must be converted to the active T3 form to exert biological effects. A low T4 alone doesn't indicate whether the problem lies in production, conversion, or utilization.

T3 (Triiodothyronine) is the metabolically active form that actually drives cellular metabolism. Low T3 with normal or elevated T4 suggests conversion problems rather than production issues.

TSH (Thyroid Stimulating Hormone) indicates pituitary demand for thyroid hormone production. However, in chronically ill horses, TSH may be suppressed due to overall metabolic stress, creating misleading results.

Reverse T4 and Reverse T3 are inactive metabolites that can accumulate during illness, stress, or poor nutrition. High levels of these compounds can block thyroid hormone receptors and create functional hypothyroidism even when T4 and T3 levels appear normal.

Research indicates that up to 7% of thyroid imbalances may be missed when TSH is used as the only marker, and routine thyroid tests miss critical information about thyroid health. This is why comprehensive thyroid panels are essential for accurate assessment.

The Lyme Disease Connection

Horses with a history of Lyme disease face additional complications that make thyroid supplementation particularly risky. Chronic Lyme disease can create persistent inflammation and immune system dysregulation that affects multiple endocrine organs. The inflammatory cytokines associated with chronic Lyme infection can interfere with thyroid hormone conversion and utilization at the cellular level, creating what appears to be hypothyroidism when the actual problem is inflammatory interference with hormone function.

Additionally, Lyme disease can damage the HPA axis, making these horses more susceptible to cortisol dysregulation (and thus increasing insulin) when exposed to thyroid hormone supplementation. The combination of existing insulin resistance and compromised adrenal function creates a perfect storm where levothyroxine supplementation can trigger dangerous metabolic decompensation.

Because Lyme disease is a system-wide infection leading to tissue inflammation in affected organs, when the thyroid becomes inflamed, it struggles to produce enough thyroid hormone. However, this inflammatory suppression is fundamentally different from primary thyroid failure and requires anti-inflammatory approaches rather than hormone replacement. All of which the current diet protocol is formulated to address.

The Adrenal-Thyroid Connection

The relationship between adrenal and thyroid function is bidirectional and complex. Healthy adrenal function is essential for proper thyroid hormone conversion and cellular uptake. Cortisol, when present in appropriate amounts, facilitates the conversion of T4 to T3 and helps transport thyroid hormones into cells. However, when adrenal function is compromised—either through exhaustion or dysregulation—this conversion process becomes inefficient.

Research shows that cortisol can interfere with the conversion of thyroid hormone T4 to T3, the active form of thyroid hormone, in the liver and other tissues. Chronic stress can have both direct and indirect effects on thyroid function, and elevated cortisol can inhibit the conversion of T4 to the more active T3 form.

Conversely, adequate thyroid function supports healthy adrenal response to stress. When apparent thyroid deficiency is actually secondary to adrenal dysfunction, providing thyroid hormone supplementation without addressing the underlying adrenal issues can worsen the problem by placing additional stress on already compromised adrenal glands.

A Systems-Based Approach

Rather than focusing on isolated hormone replacement, the functional nutrition approach we are taking emphasizes supporting the entire endocrine system to restore natural hormone production and utilization. This involves providing the nutritional building blocks necessary for healthy adrenal function, supporting the body's natural detoxification processes to reduce inflammatory burden, and addressing any lingering effects of Lyme disease through immune system support.

Research suggests that any beneficial effect of thyroid hormone administration in horses may be pharmacologic rather than physiologic, highlighting the importance of addressing root causes rather than simply replacing hormones. Key interventions typically include adaptogenic herbs that support adrenal resilience, nutrients that facilitate healthy hormone conversion (such as selenium and zinc), anti-inflammatory compounds to reduce systemic inflammation, and specific nutrients that support mitochondrial function where hormones actually exert their effects.

Clinical Implications

For the horse owner, this means that seeing a "low thyroid" test result doesn't automatically indicate a need for thyroid hormone replacement. Historical evidence shows that fat horses were thought to be hypothyroid and many horses were treated with thyroid hormone, but research has revealed that low thyroid hormone levels are actually very rare in adult horses. In fact, in horses with insulin resistance, thyroid supplementation may worsen the underlying condition and create new health risks.

For the veterinarian, this case illustrates the importance of comprehensive endocrine assessment and systems-thinking in treatment planning. Equine thyroid disorders pose a diagnostic challenge in clinical practice because of the effects of nonthyroidal factors on the hypothalamic–pituitary–thyroid axis. Rather than treating individual hormone deficiencies in isolation, addressing the root causes of endocrine dysfunction often allows natural hormone balance to restore itself without the risks associated with synthetic hormone supplementation.

The goal is not simply to normalize individual hormone levels, but to restore the natural communication and balance between endocrine organs, allowing the horse's own regulatory mechanisms to maintain appropriate hormone levels and responses. This approach is not only safer, but is often more effective in achieving long-term metabolic health and stability.

References

Bertin, F. R., Eichstadt Forsythe, L., & Kritchevsky, J. E. (2019). Effects of high doses of levothyroxine sodium on serum concentrations of triiodothyronine and thyroxine in horses. American Journal of Veterinary Research, 80(6), 565-571.

Frank, N., Elliott, S. B., & Boston, R. C. (2008). Effects of long-term oral administration of levothyroxine sodium on glucose dynamics in healthy adult horses. American Journal of Veterinary Research, 69(1), 76-81.

Frank, N., Buchanan, B. R., Elliott, S. B., Lew, J., & Boston, R. C. (2008). Effects of oral administration of levothyroxine sodium on concentrations of plasma lipids, concentration and composition of very-low-density lipoproteins, and glucose dynamics in healthy adult mares. American Journal of Veterinary Research, 69(1), 82-88.

Herman, J. P., & Tasker, J. G. (2016). Paraventricular hypothalamic mechanisms of chronic stress adaptation. Frontiers in Endocrinology, 7, 137.

Divers, T. J. (2023, July 3). Lyme disease in horses. Cornell University College of Veterinary Medicine. https://www.vet.cornell.edu/about-us/news/20230703/lyme-disease-horses

McGowan, P. O., Sasaki, A., D'Alessio, A. C., Dymov, S., Labonté, B., Szyf, M., Turecki, G., & Meaney, M. J. (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nature Neuroscience, 12(3), 342-348.

Romero, L. M. (2004). Physiological stress in ecology: lessons from biomedical research. Trends in Ecology & Evolution, 19(5), 249-255.

SRH Veterinary Services. (2018, November 17). November-Cushing's and insulin resistance in horses. https://srhveterinary.com/2018/11/17/november-cushings-and-insulin-resistance-in-horses/

Thal, D. (2024, December 17). Thyroid hormone supplementation levothyroxine sodium. Horse Side Vet Guide. https://horsesidevetguide.com/drv/Treatment/363/thyroid-hormone-supplementation-levothyroxine-sodium/